Vol 8 No 2 (2024): Pulmonology and Allergology | Pulmonology and allergology

Skip to main content Skip to main navigation menu Skip to site footer

Published: 2024-09-25

Topical Issues

Lithuanian Science Prize laureates

Žurnalo „Pulmonologija ir alergologija“ redakcija

104
- PDF (Lietuvių)
NEW GUIDELINES FOR THE PERFORMANCE AND INTERPRETATION OF SPIROMETRY

Kęstutis Malakauskas

105
- PDF (Lietuvių)
THE LITHUANIAN SCIENCE COUNCIL-FUNDED RESEARCHER CLUSTER PROJECT IS COMPLETED "BLOOD EOSINOPHIL SUBTYPE-SPECIFIC MIRNAS AS BIOMARKERS AND THERAPEUTIC AGENTS IN ASTHMA"

Eglė Vasylė

106-107
- PDF (Lietuvių)
IMPRESSIONS OF THE ANNUAL CONGRESS OF THE EUROPEAN RESPIRATORY SOCIETY

Eglė Vasylė

108-109
- PDF (Lietuvių)

Pulmonology and allergology

LITHUANIAN RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF OBSTRUCTIVE SLEEP APNEA 2024

Guoda Vaitukaitienė (redaktorė), Skaidrius Miliauskas, Edvardas Danila, Rolandas Zablockis, Tomas Balsevičius, Edita Gavelienė, Giedrė Jurkevičienė, Eugenijus Lesinskas, Kęstutis Malakauskas, Raminta Masaitienė, Valdonė Misevičienė, Evelina Pajėdienė, Dainius Razukevičius, Virginija Šileikienė, Virgilijus Ulozas, Laimutė Vaidelienė

110-128
- PDF (Lietuvių)
NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE. PROBLEMS IN DIAGNOSIS AND TREATMENT

Greta Musteikienė, Skaidrius Miliauskas

129-135
- PDF (Lietuvių)
VACCINE COMPONENTS CAUSING HYPERSENSITIVITY REACTIONS. VACCINATION OF ALLERGIC PATIENTS

Justina Šematonytė

136-143
- PDF (Lietuvių)

Disertations

MICROBIOME, IMMUNE MARKERS, AND CRYOBIOPSY DIAGNOSTIC YIELD IN THE PATIENTS WITH NON-SMALL CELL LUNG CANCER

Vytautas Ankudavičius

144-152
- PDF (Lietuvių)
PROLIFERATIVE ACTIVITY OF EOSINOPHIL SUBTYPES AND IMMUNE RESPONSE CHARACTERISTICS IN TYPE 2 ASTHMA

Jolita Palačionytė

153-165
- PDF (Lietuvių)

Scientific articles and reviews

BIOLOGICAL PROPERTIES OF EXOSOMES AND ROLE IN EOSINOPHILIC ASTHMA PATHOGENESIS

Airidas Rimkūnas, Andrius Januškevičius, Kęstutis Malakauskas

166-174
- PDF (Lietuvių)
EFFECTIVENESS OF BENRALIZUMAB IN THE TREATMENT OF PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA. LITHUANIAN DATA FROM THE BREEZE STUDY

Kęstutis Malakauskas, Kristina Biekšienė, Marius Zolubas, Jolita Palačionytė, Olga Merkutova-Petrošienė, Vytis Čižinauskas, Virginija Šileikienė

175-180
- PDF (Lietuvių)
WHOLE-GENOME SEQUENCING TO STUDY THE GENOTYPIC CHARACTERISTICS OF MULTIDRUG-RESISTANT TUBERCULOSIS MYCOBACTERIA

Žydrūnė Tautkienė, Greta Musteikienė, Skaidrius Miliauskas

181-186
- PDF (Lietuvių)

Pharmacotherapy

NINTEDANIB IMPACT ON SYMPTOMS FOR PATIENTS WITH PROGRESSIVE PULMONARY FIBROSIS

Laima Kondratavičienė

187-191
- PDF (Lietuvių)
TRIPLE THERAPY FOR EFFECTIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AND REDUCTION OF CARDIOVASCULAR EVENTS

Virginija Kalinauskaitė- Žukauskė

192-199
- PDF (Lietuvių)
REVIEW OF FIVE YEARS OF CLINICAL DATA ON THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER WITH PEMBROLIZUMAB AND CHEMOTHERAPY IN PD-L1 EXPRESSION-NEGATIVE PATIENTS

Vytautas Ankudavičius

201-206
- PDF (Lietuvių)
TREATMENT OF OBSTRUCTIVE PULMONARY DISEASE WITH BECLOMETOSONE/FORMOTEROL/GLYCOPYRRONIUM IN SINGLE INHALER. DATA FROM TRITRIAL REAL-LIFE TRIAL

Kristina Biekšienė

207-212
- PDF (Lietuvių)
THE PHARMACOKINETICS, EFFICACY, IMMUNOGENICITY, AND SAFETY OF ATEZOLIZUMAB SUBCUTANEOUS IN NON-SMALL-CELL LUNG CANCER. IMSCIN001 CLINICAL STUDY (PART 2)

Giedrė Gurevičienė

214-218
- PDF (Lietuvių)